Issue 1/2017
Content (12 Articles)
Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?
Bijan J. Borah, Naveen Pereira, Michael E. Farkouh
Next-Generation Stem Cell Therapy: Genetically Modified Mesenchymal Stem Cells for Cardiac Repair
Shathiyah Kulandavelu, Wayne Balkan, Joshua M. Hare
Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction
Leilei Chen, Yuan Zhang, Liangliang Tao, Zhijian Yang, Liansheng Wang
Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation
Yao Dai, Yongxiang Cao, Zhigao Zhang, Srikanth Vallurupalli, Jawahar L. Mehta
Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype
Russell G. Rogers, Jeffrey S. Otis
CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis
Minghuan Jiang, Joyce H. S. You
Editorial to: “Building a Bridge to the Future of Cardiovascular Drugs and Therapy”
Sean M Davidson
Cardioprotection: Where to from here?
Robert A. Kloner, Sharon L. Hale, Wangde Dai, Jianru Shi
Anthracycline Chemotherapy and Cardiotoxicity
John V McGowan, Robin Chung, Angshuman Maulik, Izabela Piotrowska, J Malcolm Walker, Derek M Yellon
Exosomes and Cardiovascular Protection
Sean M. Davidson, Kaloyan Takov, Derek M. Yellon
Mitochondrial-Shaping Proteins in Cardiac Health and Disease – the Long and the Short of It!
Sang-Bing Ong, Siavash Beikoghli Kalkhoran, Sauri Hernández-Reséndiz, Parisa Samangouei, Sang-Ging Ong, Derek John Hausenloy
Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs
Hai Ying Fu, Mikio Mukai, Nobuhisa Awata, Yasushi Sakata, Masatsugu Hori, Tetsuo Minamino